NPPA Fixes Retail Price of 15 Formulation, Detail
New Delhi: Through a recent notification, the National Pharmaceuticals Pricing Authority (NPPA) has fixed the retail of 15 scheduled formulations including Amoxycillin and Potassium Clavulanate Oral Suspension, Aceclofenac and Paracetamol Tablets, Pantoprazole (EC) and Levosulpiride (SR) Capsules and others.
This came in line with the decision of the 112 Authority meeting held on the 1st of May 2023, where the retail price fixation of 15 scheduled formulations was discussed.
The list of 15 formulations includes Malik Lifesciences & Dr Reddy's Laboratories Limited's Amoxycillin and Potassium Clavulanate Oral Suspension, East African (India) Overseas & Alkem Laboratories' Paracetamol, Phenylephrine Hydrochloride & Chlorpheniramine ine maleate Tablets, Theon Pharmaceuticals & FDC Limited's Amoxycillin & Potassium Clavulanate Tablets, Skymap Pharmaceuticals & German Remedies Pharmaceutical's Ofloxacin and Betamethasone e Sodium Phosphate Eye/ Ear Drops, Windlas Biotech &Torrent Pharmaceuticals' Tranexamic Acid and Etamsylate Tablets, Aagya Biotech & German Remedies Pharmaceutical's Aceclofenac and Paracetamol Tablets, Akums Drugs & Pharmaceuticals & Emcure Pharmaceutical's Calcium, Vitamin D3, Mecobalamin, L-Methylfolate Calcium & Pyridoxal-5- Phosphate Tablets, Ravenbhel Healthcare & Aristo Pharmaceutical's Itraconazole Capsules 65mg (Supra- Bioavailable Formulation), Alaina Healthcare & Abbott Healthcare's Chlorhexidine gluconate, Metronidazole and Lignocain Hydrochloride Gel, Ravenbhel Healthcare & Emcure Pharmaceuticals Itraconazole Capsules 65mg (Supra- Bioavailable Formulation) and Itraconazole Capsules 130mg (Supra- Bioavailable Formulation), Theon Pharmaceuticals & Cadila Pharmaceutical's Pantoprazole (EC) and Levosulpiride (SR) Capsules, AXA Parenterals & Themis Medicare's Linezolid Infusion, Swiss Garniers Biotech & Zydus Healthcare's Bisoprolol Fumarate and Amlodipine Tablets, Pure and Cure Healthcare & Zydus Healthcare's FDC Alpha Lipoic Acid plus Mecobalamin plus Myo-Inositol plus Folic Acid + Pyridoxine Hydrochloride plus Chromium Picolinate and Benfortiamine Tablets.
The notice declared that in the exercise of the powers conferred by paragraphs 5, 11, and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May 2013 and S. O.5249(E) dated 11th November 2022 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred to as NPPA), hereby fixes, the price as specified in column (6) of the table herein below as the retail price, exclusive of Goods and Services Tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof;
Sl. No . | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
1 | Amoxycillin and Potassium Clavulanate Oral Suspension (Combi pack with Sterile Water for Reconstitution of Dry Syrup) | Each combi pack contains: A. Amoxycillin and Potassium Clavulanate Oral suspension IP Composition: Each 5ml of reconstituted suspension contains: Amoxycillin Trihydrate IP eq. to Amoxycillin 600mg Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 42.9mg B. 2 Ampoules of sterile water for reconstitution of dry syrup each ampoule contains: sterile water for injection IP 25ml | Each Combi Pack | M/s Malik Lifesciences Pvt. Ltd. / M/s Dr. Reddy's Laboratories Limited | 162.1 1 |
2 | Paracetamol, Phenylephrine Hydrochloride & Chlorpheniram ine maleate Tablets | Each uncoated tablet contains: Paracetamol IP 500mg Phenylephrine Hydrochloride IP 10mg Chlorpheniramine maleate IP 2mg | 1 Tablet | M/s East African (India) Overseas / M/s Alkem Laboratories Ltd. | 4.42 |
Sl. No . | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
3 | Amoxycillin & Potassium Clavulanate Tablets IP | Each film coated tablet contains: Amoxycillin Trihydrate IP eq. to Amoxycillin 875mg Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 125mg | 1 Tablet | M/s Theon Pharmaceuticals Limited / M/s FDC Limited | 33.92 |
4 | Ofloxacin and Betamethason e Sodium Phosphat Eye / Ear Drops | Composition: Ofloxacin IP 0.3% w/v Betamethasone Sodium Phosphate IP 0.1% w/v Benzalkonium Chloride Solution IP 0.02% v/v (As preservative) | 1 ml | M/s Skymap Pharmaceuticals Pvt. Ltd./ M/s German Remedies Pharmaceuticals Pvt. Ltd. | 1.45 |
5 | Tranexamic Acid and Etamsylate Tablets | Each film coated tablet contains: Etamsylate BP 250mg Tranexamic Acid IP 500mg. | 1 Tablet | M/s Windlas Biotech Pvt. Ltd. / M/s Torrent Pharmaceuticals Ltd. | 23.37 |
6 | Aceclofenac and Paracetamol Tablets | Each film coated tablet contains: Aceclofenac IP 100mg Paracetamol IP 325mg | 1 Tablet | M/s Aagya Biotech Pvt. Ltd. / M/s German Remedies Pharmaceuticals Pvt. Ltd. | 4.83 |
7 | Calcium, Vitamin D3, Mecobalamin, L-Methylfolate Calcium & Pyridoxal-5- Phosphate Tablets | Each film coated tablet contains: Calcium Carbonate IP 1250mg eq. to Elemntal Calcium 500mg Vitamin D3 IP 2000 IU Mecobalamin IP 1500mcg L-Methylfolate Calcium 1mg Pyridoxal-5-Phosphate 20mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Emcure Pharmaceuticals Ltd. | 18.36 |
8 | Itraconazole Capsules 65mg (Supra- Bioavailable Formulation) | Each hard gelatin capsule contains: Itraconazole BP 65mg | 1 Capsule | M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Aristo Pharmaceuticals Pvt. Ltd. | 11.94 |
9 | Chlorhexidine gluconate, Metronidazole and Lignocaine | Composition: Chlorhexidine gluconate solution IP eq. to Chlorhexadine 1 % w/w, Metronidazole Bezoate | 1 GM | M/s Alaina Healthcare Pvt. Ltd. / M/s Abbott Healthcare Pvt. Ltd. | 3.75 |
Sl. No . | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
Hydrochloride Gel | IP eq. to Metronidazole 1% w/w Lignocaine Hydrochloride IP 2% w/w | ||||
10 | Itraconazole Capsules 65mg (Supra- Bioavailable Formulation) | Each hard gelatin capsule contains:Itraconazole BP 65mg | 1 Capsule | M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Emcure Pharmaceuticals Limited | 11.94 |
11 | Itraconazole Capsules 130mg (Supra- Bioavailable Formulation) | Each hard gelatin capsule contains: Itraconazole BP 130mg | 1 Capsule | M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Emcure Pharmaceuticals Limited | 20.72 |
12 | Pantoprazole (EC) and Levosulpiride (SR) Capsules | Each hard gelatin capsule contains: Pantoprazole Sodium IP eq. to Pantoprazole 40mg (as enteric coated pellets) Levosulpiride 75mg (As sustained release pellets) | 1 Capsule | M/s Theon Pharmaceuticals Ltd. / M/s Cadila Pharmaceuticals Ltd. | 16.15 |
13 | Linezolid Infusion | Each 100ml contains: Linezolid IP 200mg Dextrose (Anhydrous) 5% w/v Water for Injection IP | 1 ml | M/s AXA Parenterals Ltd. / M/s Themis Medicare Limited | 1.36 |
14 | Bisoprolol Fumarate and Amlodipine Tablets | Each film coated tablet contains: Bisoprolol Fumarate IP 5mg Amlodipine Besylate IP Eq. to Amlodipine 5mg | 1 Tablet | M/s Swiss Garniers Biotech Pvt. Ltd. / M/s Zydus Healthcare Limited | 8.34 |
15 | Alpha Lipoic Acid + Mecobalamin + Myo-Inositol + Folic Acid + Pyridoxine Hydrochloride + Chromium Picolinate and Benfortiamine Tablets | Each film coated table contains: Alpha Lipoic Acid IP 200mg Mecobalamin IP 1500mcg Myo-Inositol IP 100mg Folic Acid IP 1.5mg Pyridoxine Hydrochloride IP 3mg Chromium Picolinate IP eq. to Elemental | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd. / M/s Zydus Healthcare Limited | 22.86 |
Sl. No . | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
chromium 200mcg Benfortiamine 200mg |
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd